Latest Market Activity News

Cyclone Metals Limited's shares have been suspended from trading on the ASX due to a non-compliant announcement, leaving investors in limbo until a suitable update is provided.

Vital Metals Limited has had its trading suspension lifted following announcements addressing an ASX Price and Volume Query and a new capital raise, signaling renewed market activity.

WAM Microcap Limited has outperformed the ASX Small Ordinaries Index for the eighth consecutive year, posting an 18.8% portfolio gain and raising its fully franked dividend to 10.6 cents per share.

GDI Property Group reports robust leasing activity with over 32,000sqm leased in FY25, fueling a 20% increase in Funds From Operations. Strategic asset sales and refinancing position the company well for continued growth in a tightening Perth office market.

Reece Limited reported a modest revenue decline and a sharper drop in profits for FY25, reflecting subdued demand in key markets and ongoing investment in growth. The company declared a reduced fully franked dividend as it navigates a challenging housing environment.

Health and Plant Protein Group Limited (HPP) reported a reduced net loss of $528,000 for FY2025, following the receipt of final proceeds from its US divestment. The Board signals plans to return capital and pursue new corporate opportunities.

Cannindah Resources Limited has had its trading suspension lifted immediately following the release of a capital raising announcement, signaling renewed market activity.

Omnia Metals Group Limited has issued a prospectus to list up to 10,000 options, aiming to remove trading restrictions and facilitate secondary market activity. This move follows recent capital raisings and shareholder approvals, positioning the company for enhanced liquidity.

Zip Co has delivered a standout FY25 with cash earnings soaring 147%, driven by rapid US market expansion. The company is now considering a Nasdaq dual listing to fuel further growth.

MA Financial Group reported a robust 30% revenue increase for the first half of 2025, yet statutory net profit fell sharply by 44%, highlighting a complex financial landscape as the firm prepares to acquire IP Generation.

Whitehaven Coal Limited has announced a fully franked ordinary dividend of AUD 0.06 per share for the six months ending June 2025, signaling steady returns for shareholders.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.